Soluble vascular adhesion protein-1: Decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1678-1682

  Lin, Zhexuan ^a   Han, Ming ^a   Li, Hui ^a   Luo, Hongjun ^a   Zhang, Yuan ^a   Luo, Wenhong ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Glasgow Coma Scale; Inflammation; Injury severity score; Soluble vascular adhesion protein 1; Trauma; Traumatic brain injury

Indexed keywords

SOLUBLE VASCULAR ADHESION PROTEIN 1; UNCLASSIFIED DRUG; VASCULAR ADHESION PROTEIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLASGOW COMA SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INJURY SCALE; INJURY SEVERITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL MARKERS; BRAIN INJURIES; CELL ADHESION MOLECULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 79959298803     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.031     Document Type: Article

References (44)

1. Wang Z.G. The research progress of trauma. J Clin Surg 2007, 15:727-730.
2. Wang Z.G. Advancement in research of trauma. J Chengdu Med Coll 2006, 1:2-4.
3. Marshall J.C., Vincent J.L., Fink M.P., Cook D.J., Rubenfeld G., Foster D., et al. Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003, 31:1560-1567.
4. Roumen R.M., Hendriks T., van der Ven-Jongekrijg J., Nieuwenhuijzen G.A., Sauerwein R.W., van der Meer J.W., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993, 218:769-776.
5. Lenz A., Franklin G.A., Cheadle W.G. Systemic inflammation after trauma. Injury 2007, 38:1336-1345.
6. Sauaia A., Moore F.A., Moore E.E., Moser K.S., Brennan R., Read R.A., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995, 38:185-193.
7. Lenz A., Franklin G.A., Cheadle W.G. Systemic inflammation after trauma. Injury 2007, 38:1336-1345.
8. Maier B., Lefering R., Lehnert M., Laurer H.L., Steudel W.I., Neugebauer E.A., et al. Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 2007, 28:668-674.
9. Boldt J., Muller M., Kuhn D., Linke L.C., Hempelmann G. Circulating adhesion molecules in the critically ill: a comparison between trauma and sepsis patients. Intensive Care Med 1996, 22:122-128.
10. Castelli G.P., Pognani C., Cita M., Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37:1845-1849.
11. Arand M., Melzner H., Kinzl L., Brückner U.B., Gebhard F. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbecks Arch Surg 2001, 386:241-248.
12. McKeating E.G., Andrews P.J., Mascia L. The relationship of soluble adhesion molecule concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Anesth Analg 1998, 86:759-765.
13. Magyar K., Mészáros Z. Semicarbazide-sensitive amine oxidase (SSAO): present and future. Inflammopharmacology 2003, 11:165-173.
14. El Hadri K., Moldes M., Mercier N., Andreani M., Pairault J., Feve B. Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler Thromb Vasc Biol 2002, 22:89-94.
15. Zorzano A., Abella A., Marti L., Carpéné C., Palacín M., Testar X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta 2003, 1647:3-9.
16. Jaakkola K., Nikula T., Holopainen R., Vahasilta T., Matikainen M.T., Laukkanen M.L., et al. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am J Pathol 2000, 157:463-471.
17. Vainio P.J., Kortekangas-Savolainen O., Mikkola J.H., Jaakkola K., Kalimo K., Jalkanen S., et al. Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis. Basic Clin Pharmacol Toxicol 2005, 96:429-435.
18. Abella A., García-Vicente S., Viguerie N., Ros-Baró A., Camps M., Palacín M., et al. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 2004, 47:429-438.
19. Boomsma F., Pedersen-Bjergaard U., Agerholm-Larsen B., Hut H., Dhamrait S.S., Thorsteinsson B., et al. Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus. Diabetologia 2005, 48:1002-1007.
20. Garpenstrand H., Ekblom J., Bäcklund L.B., Oreland L., Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet Med 1999, 16:514-521.
21. Madej A., Reich A., Orda A., Szepietowski J.C. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J Eur Acad Dermatol Venereol 2007, 21(1):72-78.
22. Toiyama Y., Miki C., Inoue Y., Kawamoto A., Kusunoki M. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol 2009, 99:368-372.
23. Li H., Luo W., Lin J., Lin Z., Zhang Y. Assay of plasma semicarbazide-sensitive amine oxidase and determination of its endogenous substrate methylamine by liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 810:277-282.
24. Stanimirovic D.B., Wong J., Shapiro A., Durkin J.P. Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults. Acta Neurochir Suppl 1997, 70:12-16.
25. Bazil V. Physiological enzymatic cleavage of leukocyte membrane molecules. Immunol Today 1995, 16:135-140.
26. Salmi M., Yegutkin G.G., Lehvonen R., Koskinen K., Salminen T., Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity 2001, 14:265-276.
27. Yang W., Li H., Lin Z., Luo W. Role of semicarbazide-sensitive Amine Oxidase in Myocardial ischemia-reperfusion Injury. Chin J Pharmacol Toxicol 2009, 23:337-344.
28. Airas L., Mikkola J., Vainio J.M., Elovaara I. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J Neuroimmunol 2006, 177:132-135.
29. Karádi I., Mészáros Z., Csányi A., Szombathy T., Hosszúfalusi N., Romics L., et al. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis. Clin Chim Acta 2002, 323:139-146.
30. Kivi E., Elima K., Aalto K., Nymalm Y., Auvinen K., Koivunen E., et al. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood 2009, 114:5385-5392.
31. Schleiffenbaum B., Spertini O., Tedder T.F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992, 119:229-238.
32. Meyer D.M., Dustin M.L., Carron C.P. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol 1995, 155:3578-3584.
33. Obata T., Yamanaka Y. Evidence for existence of immobilization stress-inducible semicarbazide-sensitive amine oxidase inhibitor in rat brain cytosol. Neurosci Lett 2000, 296:58-60.
34. Werner C., Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007, 99:4-9.
35. Dalfó E., Hernandez M., Lizcano J.M., Tipton K.F., Unzeta M. Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma. Biochim Biophys Acta 2003, 1638:278-286.
36. Bayir H., Tyurin V.A., Tyurina Y.Y., Viner R., Ritov V., Amoscato A.A., et al. Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann Neurol 2007, 62:154-169.
37. Pasvogel A.E., Miketova P., Moore I.M. Cerebrospinal fluid phospholipid changes following traumatic brain injury. Biol Res Nurs 2008, 10:113-120.
38. Freestone P.P., Williams P.H., Haigh R.D., Maggs A.F., Neal C.P., Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 2002, 18:465-470.
39. Gecse A., Horpácsy G., Karády S. Histamine liberation and histamine formation in traumatic shock and in shock-resistance. II. Histamine formation. Med Exp Int J Exp Med 1969, 19:279-286.
40. Stokely M.E., Orr E.L. Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J Neurotrauma 2008, 25:52-61.
41. Arand M., Melzner H., Kinzl L., Brückner U.B., Gebhard F. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbecks Arch Surg 2001, 386:241-248.
42. Linn S. The injury severity score-importance and uses. Ann Epidemiol 1995, 5:440-446.
43. Somfai G.M., Knippel B., Ruzicska E., Stadler K., Tóth M., Salacz G., et al. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Neurochem Int 2006, 48:746-752.
44. Lin Z., Luo W., Li H., Zhang Y. The effect of endogenous formaldehyde on the rat aorta endothelial cells. Toxicol Lett 2005, 159:134-143.